Results 51 to 60 of about 35,205 (135)
BackgroundAndrogenetic alopecia is the most prevalent form of progressive hair loss. Minoxidil is widely regarded as a standard treatment for this condition.
Yinfeng Xia +3 more
doaj +1 more source
Androgenetic alopecia (AGA) is the most common form of patterned hair loss, exhibiting gender-specific clinical features. Recent studies highlight the importance of the skin microbiome in maintaining skin health, but the relationship between the hair ...
Yujun Park +12 more
doaj +1 more source
Background Female pattern hair loss (FPHL) is a disease characterized by progressive hair thinning. Topical minoxidil is an FDA-approved drug for the treatment of androgenetic alopecia. Dutasteride (a 5α-reductase inhibitor) can also be used in a topical
Reham Essam, Heba Selim, Rana Ehab
doaj +1 more source
Alopecia or baldness is a common problem that can cause worry and stress to patients. The evaluation of hair loss remains a difficult and confusing subject for most physicians.
S Thaichinda
doaj
Background and Aim: Female pattern hair loss(female androgenic alopecia) is a common but puzzling condition in women which increases by aging. Female hair loss is strongly linked to hormones and hormonal imbalances. The aim of this study was to determine
Anahita Moaven +5 more
doaj +2 more sources
Association between Family History and Male Androgenetic Alopecia with Female Pattern Hair Loss. [PDF]
Lee SH, Kang H, Lee WS.
europepmc +1 more source
Differences in Demographic and Clinical Characteristics Among Subtypes of Female Pattern Hair Loss. [PDF]
Sakpuwadol N +4 more
europepmc +1 more source
The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis. [PDF]
Aleissa M.
europepmc +1 more source
Marwa S. Zaki, Iman Z. Ahmed
openaire +1 more source

